Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuma Tokunaga

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Clinical Colorectal Cancer|October 9, 2018
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based ChemotherapyRyuma Tokunaga, Shu Cao, Madiha Naseem, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 16, 2018
Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinomaShigeki Nakagawa, Hirohisa Okabe, Mayuko Ouchi, et al.
Surgery Today|October 10, 2014
A clinicopathological analysis of primary mucosal malignant melanomaDaisuke Izumi, Takatsugu Ishimoto, Naoya Yoshida, et al.
BMC Cancer|July 9, 2016
Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature reviewKazuto Harada, Yoshifumi Baba, Hironobu Shigaki, et al.
Scientific Reports|June 10, 2021
Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patientsMadiha Naseem, Shu Cao, Dongyun Yang, et al.
Annals of Surgical Oncology|July 11, 2020
Fibrosis-4 Index, a Noninvasive Fibrosis Marker, Predicts Survival Outcomes After Hepatectomy for Colorectal Cancer Liver MetastasesTakahiko Akiyama, Yuji Miyamoto, Katsunori Imai, et al.
Molecular Cancer Therapeutics|March 31, 2021
RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICCHiroyuki Arai, Shu Cao, Francesca Battaglin, et al.
Journal of Gastroenterology|December 17, 2015
Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinomaDasiuke Izumi, Naoya Yoshida, Masayuki Watanabe, et al.
Medical Oncology (Northwood, London, England)|March 19, 2015
Relationship between LINE-1 hypomethylation and Helicobacter pylori infection in gastric mucosaeKeisuke Kosumi, Yoshifumi Baba, Takatsugu Ishimoto, et al.
Oncotarget|March 3, 2016
Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinomaRyuma Tokunaga, Yu Imamura, Kenichi Nakamura, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Clinical Colorectal Cancer|October 9, 2018
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based ChemotherapyRyuma Tokunaga, Shu Cao, Madiha Naseem, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 16, 2018
Enhancer of zeste homolog 2 (EZH2) regulates tumor angiogenesis and predicts recurrence and prognosis of intrahepatic cholangiocarcinomaShigeki Nakagawa, Hirohisa Okabe, Mayuko Ouchi, et al.
Surgery Today|October 10, 2014
A clinicopathological analysis of primary mucosal malignant melanomaDaisuke Izumi, Takatsugu Ishimoto, Naoya Yoshida, et al.
BMC Cancer|July 9, 2016
Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature reviewKazuto Harada, Yoshifumi Baba, Hironobu Shigaki, et al.
Scientific Reports|June 10, 2021
Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patientsMadiha Naseem, Shu Cao, Dongyun Yang, et al.
Annals of Surgical Oncology|July 11, 2020
Fibrosis-4 Index, a Noninvasive Fibrosis Marker, Predicts Survival Outcomes After Hepatectomy for Colorectal Cancer Liver MetastasesTakahiko Akiyama, Yuji Miyamoto, Katsunori Imai, et al.
Molecular Cancer Therapeutics|March 31, 2021
RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICCHiroyuki Arai, Shu Cao, Francesca Battaglin, et al.
Journal of Gastroenterology|December 17, 2015
Tumor/normal esophagus ratio in (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for response and prognosis stratification after neoadjuvant chemotherapy for esophageal squamous cell carcinomaDasiuke Izumi, Naoya Yoshida, Masayuki Watanabe, et al.
Medical Oncology (Northwood, London, England)|March 19, 2015
Relationship between LINE-1 hypomethylation and Helicobacter pylori infection in gastric mucosaeKeisuke Kosumi, Yoshifumi Baba, Takatsugu Ishimoto, et al.
Oncotarget|March 3, 2016
Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinomaRyuma Tokunaga, Yu Imamura, Kenichi Nakamura, et al.
Pageof 8